Drug application

M.V.I. ADULT (ASCORBIC ACID, BIOTIN, CYANOCOBALAMIN and 10 more)

Drugs@FDA NDA 021625 · HOSPIRA

Key facts

Drug name M.V.I. ADULT
Active ingredients ASCORBIC ACID, BIOTIN, CYANOCOBALAMIN, DEXPANTHENOL, ERGOCALCIFEROL, FOLIC ACID, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN 5'-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, VITAMIN A, VITAMIN E and 1 more
Application type NDA
Application number 021625
Company HOSPIRA
Dosage forms INJECTABLE, INTRAVENOUS
Strength 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
Marketing status Discontinued
Reference listed drug Yes
Latest submission class Type 3 - New Dosage Form
Latest submission status date Jan 30, 2004

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • 1–9 Label versions
  • 1–9 Products
  • None Therapeutic equivalents
  • Yes FDA letters on file
  • Yes FDA reviews on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date:

Browse all Drugs@FDA applications